SCHEMBL9891122

SCHEMBL9891122

CCCCCCCCCCCCC(CCCCCCCCCC)CN1C(=O)C2=C(c3ccc(-c4ccc(-c5ccc(C)s5)s4)s3)N(CC(CCCCCCCCCC)CCCCCCCCCCCC)C(=O)C2=C1c1ccc(C)s1

nearest known ligand 0.33

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
HSF1 Q00613 2/20 0.33
MAPT P10636 3/20 0.32
MEN1 O00255 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
ATM Q13315 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15614776 1.00 ALDH1A1 (0.33) ALDH1A1KMT2AKDM4ETHRBHPGD
SCHEMBL18877429 1.00 ALDH1A1 (0.33) ALDH1A1KMT2AKDM4ETHRBHPGD
SCHEMBL16154640 1.00 ALDH1A1 (0.33) ALDH1A1KMT2AKDM4ETHRBHPGD
SCHEMBL18877424 1.00 ALDH1A1 (0.33) ALDH1A1KMT2AKDM4ETHRBHPGD
SCHEMBL12194241 1.00 ALDH1A1 (0.33) ALDH1A1KMT2AKDM4ETHRBHPGD
SCHEMBL16977963 1.00 ALDH1A1 (0.33) ALDH1A1KMT2AKDM4ETHRBHPGD
SCHEMBL1689866 1.00 ALDH1A1 (0.33) ALDH1A1KMT2AKDM4ETHRBHPGD
SCHEMBL15000891 1.00 ALDH1A1 (0.33) ALDH1A1KMT2AKDM4ETHRBHPGD
SCHEMBL16522149 1.00 ALDH1A1 (0.33) ALDH1A1KMT2AKDM4ETHRBHPGD
SCHEMBL18877425 0.98 ALDH1A1 (0.34) ALDH1A1KMT2AKDM4ETHRBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11860536-B2 Three-dimensional crosslinker composition and method of manufacturing electronic devices using the same UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) 2024-01-02 US disclosed
US-9847489-B1 Polymer, method of preparing the same, and organic optoelectric device including the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2017-12-19 US disclosed
US-9074050-B2 Process for the production of polymers by using coupling reactions BASF SE (DE) 2015-07-07 US disclosed
US-20150056746-A1 DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC FIELD EFFECT TRANSISTORS BASF SE (DE) 2015-02-26 US disclosed
US-8835579-B2 Process for polymerising (hetero)aromatic compounds BASF SE (DE) 2014-09-16 US disclosed
US-20140080994-A1 PROCESS FOR THE PRODUCTION OF POLYMERS BY USING COUPLING REACTIONS BASF SE (DE) 2014-03-20 US disclosed
US-20120142872-A1 PROCESS FOR POLYMERISING (HETERO)AROMATIC COMPOUNDS BASF SE (DE) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11860536-B2 Three-dimensional crosslinker composition and method of manufacturing electronic devices using the same BMI1, SETDB1, EED ALDH1A1 149/4885KMT2A 572/4885KDM4E 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.